Evaluating preclinical efficacy.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 21849661.
- Also identified by DOI 10.1126/scitranslmed.3002757.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent disappointing results of clinical trials seeking type 1 diabetes (T1D) reversal suggest the need for a reevaluation of our translational efforts. This Commentary explores the need for standards in evaluating therapeutic efficacy in preclinical models of T1D.
Medical subject headings
- Diabetes Mellitus, Type 1